Check out Dr. Gina talking about all things health with Ron and Lisa!
LDN stands for Low Dose Naltrexone that is used off label for a variety of inflammatory conditions. There is a small but growing group of doctors who report seeing good results using this therapy for symptoms that linger once a patient has had Covid -19 (“Post Covid Syndrome”).
Something to consider…I and many of my trusted colleagues have seen great results using LDN in the field.
A recent study points to the connection between vitamin D3 deficiency and treatment, and Covid-19 infection. At my medical practice, we test the blood for Vitamin D3 levels in nearly every one of our patients as it is associated with inflammation, immune function and even mood.
Here are the details:
Our group 21 Day Purification Program is kicking off in January! Get the support you need to succeed. Everyone that completes the program receives a free bottle of physician recommended vitamin D3 5000 IU! Lower inflammation, get healthy and get strong in 2021!!!!!
Hang in there,
Glutathione (GSH) has gained massive popularity because of its benefits that involve every organ system. Most notably, Glutathione is associated with the respiratory system and its effects on upper and lower respiratory infections.
Let’s take a look at Glutathione and its connection with respiratory health.
What is Glutathione?
Glutathione is a potent antioxidant that reduces oxidative stress by neutralizing reactive oxygen species (ROS), which are known to cause tissue damage and increase the risk of a wide range of diseases, including cardiovascular disease, diabetes, and neurocognitive illnesses. This compound is produced by the cell using three main amino acids; glutamine, glycine, and cysteine.
Glutathione is found in plants, animals, and even microbes (e.g. fungi, bacteria).
How does Glutathione help with respiratory health?
Glutathione has recently surfaced as a potential treatment for multiple respiratory conditions, including chronic diseases. In one paper published by Evidence-Based Complementary and Alternative Medicine, scientists reviewed a large database of studies and clinical trials from reputable sources, such as Biomedical Reference Collection, MEDLINE, and Nursing and Allied Health Collection.
They concluded that Glutathione offers positive results to patients with respiratory diseases, stating that “GSH inhalation is an effective treatment for a variety of pulmonary diseases and respiratory-related conditions. Even very serious and difficult-to-treat diseases (e.g., CF, IPF) yielded benefits from this novel treatment.”
These findings suggest that even chronic diseases such as cystic fibrosis and idiopathic pulmonary fibrosis can benefit from glutathione.
Glutathione works in these cases by eradicating free radicals intracellularly, and reducing inflammation.
Another recent study found that a variety of potent antioxidants (e.g. Glutathione) could be implemented to reduce the severity and duration of viral infections.
These results suggest that glutathione may be effective in the treatment of several respiratory conditions, which is not the case for every drug out there.
Glutathione and COVID-19
COVID-19 causes acute severe respiratory distress in a small subset of patients, leading to the following symptoms:
– Severe dyspnea (shortness of breath)
– Myocarditis (inflammation of the heart muscle)
– Organ failure
The pathophysiology behind this presentation is thought to be the result of a “cytokine storm syndrome.“
In two case studies, experts tried the inhaled and oral forms of glutathione to treat two COVID-19 positive patients from New York.
Patients’ symptoms improved after one hour of administration, and succeeding doses gave similar results.
These findings are preliminary, but may offer a clue towards finding medicines that will work to help patients suffering from COVID-19.
Glutathione is a tripeptide that offers several health benefits due to its antioxidant properties.
In our medical practice I use glutathione regularly to treat patients.
If you have any questions about this compound, feel free to ask in the comment section below!
An interesting article was published this week in Psychology Today that talks about how inflammation in the body not only causes depression but also alters our mood and even decision making.
About 15 years ago I began to study this link. I even purchased the domain address inflamedbrain.com because I felt that one day this information would become mainstream.
And here we are!
The approach I take to treating patients often involves recommendations that lower inflammation in the body.
The fields of psychology and even sociology will likely evolve to incorporate this new information about how to help people lead more focused and clear lives.
A new study was published that highlights the link between inflammation in the body and mental illness. This is an area that I have been focusing on clinically and in training to physicians and pharmacists for the past twelve years, referring to the condition as “Sickness Syndrome.” There is a very clear link between inflammation in the body and mental illness. Addressing inflammation with a clear plan alleviates many of the symptoms associated with it including depression, anxiety and OCD. For long lasting results, we have to treat the cause of these symptoms rather then masking them. It doesn’t mean psychiatric medications are not helpful, it means we need to broaden the treatment to address one of the underlying causes-inflammation. I have been researching and working with several forms of glutathione in clinical practice as a simple and effective treatment for “neuroinflammation.” This is an exciting time in medicine, with wonderful discoveries and connections being made that will help children and adults to experience more freedom and to think more clearly.
It was an honor to speak in London on July 6th at the 2018 International Congress on Naturopathic Medicine on Glutathione, Detoxification and Neuroinflammation. There were 55 countries represented by nearly 600 physician attendees. Great audience, excellent venue. #icnm2018